Abstract:Yellow fever (YF), a mosquito-borne viral hemorrhagic fever, is endemic in Uganda and causes frequent outbreaks. A total of 1.6 million people were vaccinated during emergency mass immunization campaigns in 2011 and 2016. This study explored local perceptions of YF emergency mass immunization among vulnerable groups to inform future vaccination campaigns. In this qualitative study, we conducted 43 semi-structured interviews, 4 focus group discussions, and 10 expert interviews with 76 participants. Data were collected in six affected districts with emergency mass vaccination. We included vulnerable groups (people ≥ 65 years and pregnant women) who are typically excluded from YF vaccination except during mass immunization. Data analysis was conducted using grounded theory. Inductive coding was utilized, progressing through open, axial, and selective coding. Participants relied on community sources for information about the YF mass vaccination. Information was disseminated door-to-door, in community spaces, during religious gatherings, and on the radio. However, most respondents had no knowledge of the vaccine, and it was unclear to them whether a booster dose was required. In addition, the simultaneous presidential election during the mass vaccination campaign led to suspicion and resistance to vaccination. The lack of reliable and trustworthy information and the politicization of vaccination campaigns reinforced mistrust of YF vaccines. People in remote areas affected by YF outbreaks rely on community sources of information. We therefore recommend improving health education, communication, and engagement through respected and trusted community members. Vaccination campaigns can never be seen as detached from political systems and power relations. Yellow fever is transmitted by mosquitoes in tropical regions of South America and Africa. It can cause severe illness and death. Yellow fever can be prevented with a vaccine. However, people in several affected regions are not vaccinated because the vaccine is expensive and not part of routine immunization. For them, access to the vaccine is only possible during emergency mass vaccination campaigns when an outbreak occurs. In this study, we explored local perceptions of emergency yellow fever mass vaccination among vulnerable groups (people over 65 years and pregnant women) in Uganda to understand better how these people have access to vaccine information, what information reaches affected communities, what motivates people to be vaccinated, and what political motives may influence vaccination programs. Despite extensive campaigns, we found that the information reaching communities varied widely, with people relying heavily on community sources. In addition, the lack of trustworthy information and the politicization of vaccination campaigns increased mistrust of yellow fever vaccines. We also found that informed consent is only possible if the principle of vaccination—protection from disease—is understood. Awareness campaigns should focus on a broad understanding of the importance of immunization. Those involved in organizing campaigns should be aware of the potential impact of politicization on vaccine uptake.

Off-Label Yellow Fever and Hepatitis A Vaccination in Traveling Children

Monitoring the Efficacy of Infant Hepatitis B Vaccination and Revaccination in 0- to 8-Year-old Children: Protective Anti-Hbs Levels and Cellular Immune Responses.

Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression

Adverse events following immunization (AEFI) with fractional one-fifth and one-half doses of yellow fever vaccine compared to full dose in children 9–23 months old in Uganda, 2019–2020 — Preliminary report

Incomplete Vaccination among Children with Special Health Care Needs in Zhejiang, China: Analysis of Retrospective Data

Immune response to co-administration of measles, mumps, and rubella (MMR), and yellow fever vaccines: a randomized non-inferiority trial among one-year-old children in Argentina

Reasons of the Delayed Vaccination, Recommendations and Safety of Vaccination in Children with Congenital Heart Disease in Zhejiang, China.

Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: A population-based retrospective cohort study.

Yellow fever – An old foe with new developments

Yellow Fever: A Perennial Threat

Yellow fever vaccine coverage and associated factors among under-five children in Kenya: Data from Kenyan Demographic and Health Survey 2022

Immune response induced by standard and fractional doses of 17DD yellow fever vaccine

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease

Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects

Vaccine-derived Yellow Fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with Sofosbuvir

Acute hepatitis A in international travellers: a GeoSentinel analysis, 2008-2020

Adverse Effects Related to Paediatric Influenza Vaccination and Its Influence on Vaccination Acceptability. The FLUTETRA Study: A Survey Conducted in the Region of Murcia, Spain

Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics

Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights

A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine.

Perceptions of yellow fever emergency mass vaccinations among vulnerable groups in Uganda: A qualitative study